R. Dworakowski "It's an ideal valve to be used for patients who may require future coronary interventions"
Discover what M. Van Wely, W-K. Kim, S. Khogali, M. Ozkor and R. Dworakowski think about Navitor™ and future interventions
Learn More:
Related Videos
Index TAVI strategies for lifetime patient management
TAVI Symposium | PCR LV 2025
TAVI webinar - key learnings in TAVI
Now you've got Navitor
VANTAGE study roundtable on clinical outcomes
VANTAGE study insights by M. Adamo
VANTAGE study insights by B. Gonska
VANTAGE study insights by N. Van Mieghem